Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023

不妊治療の世界市場予測(~2023年)

◆タイトル:Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023
◆商品コード:MD-3765
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年11月6日
◆ページ数:177
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"不妊治療の世界市場予測(~2023年)"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の機会と課題、市場の動態、技術別分析、製品別分析、種類別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、主要企業(ベンダー)分析等の情報をお届けいたします。

The market for infertility treatment market is expected to grow from USD 1.5 billion in 2018 to USD 2.2 billion by 2023, at a compound annual growth rate (CAGR) of 8.0% during the forecast period. Growth in the infertility treatment market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants.

【レポートの目次】

[176 Pages Report] The market for infertility treatment market is expected to grow from USD 1.5 billion in 2018 to USD 2.2 billion by 2023, at a compound annual growth rate (CAGR) of 8.0% during the forecast period. Growth in the infertility treatment market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants.

Infertility Treatment Market

By product, the media and consumables segment is expected grow at the highest rate during the forecast period

Commercially available culture media has various components, including nutrients, vitamins, and growth factors. The growth of this segment is attributed to the increasing awareness of infertility treatment and diagnosis globally. Another factor contributing to the market growth of this segment is the easy availability of different media and consumables across various regions.

By procedure, artificial insemination is expected to be the second largest contributor to the infertility treatment market

The key factors attributed to the large share of this segment include limited risk of complications during pregnancy and high success rate achieved by the couple. The artificial insemination market is subsegmented into three major types, namely, intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination segment holds the largest share in the artificial insemination segment. The growth of this market is attributed low risks of multiple births and with high number of live births.

By patient type, female infertility treatment is expected to hold the larger share in the infertility treatment market

Infertility is one of the common conditions diagnosed among women. The growing female infertility rates, availability of a variety of treatment options, increasing awareness among women about infertility treatments, and the growing number of fertility centers are the major factors contributing to the growth of this segment.

By end user, hospitals and surgical clinics are expected to second largest contributor to the infertility treatment market

Infertility treatments in hospitals are supported by other departments (such as neonatal intensive care units), and hospitals offer complete maternity treatment till childbirth. Initiatives undertaken by governments to increase the number of hospitals equipped to perform infertility treatment procedures such as IVF and the increasing number of surgical centers providing surgical options for the treatment of infertility is expected to drive the growth of this end user segment.

North America is expected to hold a significant share in the infertility treatment market during the forecast period

Factors such as decreasing fertility rates, growing median age of first-time pregnancy, increase in healthcare expenditure, and presence of major players in this region (such as The Cooper Companies, Inc., Cook Group Incorporated, and Hamilton Throne Ltd.) are driving the growth of the infertility treatment market in North America.

Infertility Treatment Market

Market Dynamics

Growth in the infertility treatment market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants. Growth opportunities in emerging markets and the use of fertility treatment options by single parents and same-sex couples are also expected to provide opportunities for players in this market. On the other hand, the high procedural cost of assisted reproductive techniques in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.

Driver: Declining fertility rate

Infertility is the inability of an individual to achieve clinical pregnancy. Fertility rates measure the average number of children per woman. The fertility rate worldwide is declining steadily owing to various factors such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment devices that determine the fertility window in males and females.

Restraint: High procedural cost of assisted reproductive techniques in developed markets

Along with fertility surgeries, thousands of cycles of ART procedures such as in vitro fertilization (IVF) are performed every year globally. The cost of IVF treatment varies from country to country due to lack of reimbursement policies. The average cost of one IVF cycle is USD 12,000 excluding the cost of medications; if the couple goes through three cycles, the out-of-pocket expense adds up to USD 33,000. On the other hand, the average cost of one IVF cycle in developing countries such as India ranges from USD 814.74 to USD 1,086.32, including all medications. Thus, the high cost of assisted reproductive techniques coupled with lack of insurance coverage in developed countries is restraining the growth of this market.

Infertility Treatment Market

Scope of the Report

Report Metric

Details

Market Size Available for Years 2016–2023
Base Year Considered 2017
Forecast Period 2016–2023
Forecast Units Value (USD)
Segments Covered Product, Procedure, Patient Type, End User, and Region
Geographies Covered North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW (Latin America and Middle East)
Companies Covered The Cooper Companies Inc.  (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SoMATEX Medical Technologies GmbH (Germany). Major 15 players covered.

This research report categorizes the infertility treatment market based on the following:

Infertility Treatment Market, By Product

  • Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulators Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Media & Consumables
  • Accessories

Infertility Treatment Market, By Procedure

  • Assisted Reproductive Technology
  • In Vitro Fertilization
  • Intracytoplasmic morphologically-selected sperm injection (IMSI)
  • Gamete Donation
  • Intracytoplasmic Sperm Injection (ICSI)
  • Surrogacy
  • Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
  • Fertility Surgery
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction
  • Vasovasostomy
  • Vasoepididymostomy
  • Other Infertility Treatment Procedures

Infertility Treatment Market, By Patient Type

  • Female Infertility Treatment
  • Male Infertility Treatment

Infertility Treatment Market, By End User

  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

Infertility Treatment Market, By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World
    • Latin America
    • Middle East & Africa

Key Market Players

The Cooper Companies Inc.  (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SoMATEX Medical Technologies GmbH (Germany), among others.

The Cooper Companies Inc. (US) dominated the global infertility treatment market in 2017. The company has a strong foothold in the infertility treatment market, with a broad range of product offerings. The company’s CooperSurgical business (specializing in women’s health) offers a broad range of innovative technologies and services to clinicians and patients worldwide. The company has a strong distribution network in around 100 countries and has its presence across the US and Europe.

Cook Group Incorporated (US) held the second-largest market position in the global infertility treatment market in 2017. The company is present across major countries, such as Australia, Canada, Denmark, Ireland, and the US, and distributes its products in 135 countries. Cook focuses on strengthening its market position by adopting inorganic growth strategies (such as expansions and collaborations).

Recent Developments:

  • In March 2018, Vitrolife AB (Sweden) received approval for the sale of its time-lapse incubator EmbryoScope+ in the US. Through this the company expanded its product sale and market visibility in the US infertility treatment market.
  • In March 2018, Genea Limited (Australia) expanded its market presence in Melbourne by establishing a new fertility clinic in Melbourne
  • In April 2018, Baker Ruskinn (UK) entered into a partnership with I&L Biosystems UK Ltd. (UK) as its UK sales partner with the aim to expand its sales and distribution and strengthen its presence in the UK market

Key questions addressed by the report:

  • Which of the product segment will dominate the infertility treatment market in future?
  • Emerging countries have immense opportunities for the growth and adoption of infertility treatment, will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid to long term?
  • Low procedural costs in the emerging market is impacting the growth for developed markets due to cost difference among procedures. How will pricing difference impact the overall market?
  • What are the upcoming procedures in the infertility treatment market?

 


 

 

Table of Contents

 

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

 

2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.3 Market Size Estimation
2.1.3.1 Product-Based Market Estimation
2.1.4 Primary Research Validation
2.2 Market Breakdown and Data Triangulation
2.2.1 Limitations
2.2.2 Assumptions for the Study

 

3 Executive Summary  (Page No. – 32)

 

4 Premium Insights (Page No. – 36)
4.1 Infertility Treatment Market: Overview
4.2 Geographic Analysis: Market, By Product
4.3 Asia Pacific: Market Share, By Procedure (2018)
4.4 Market, By Patient Type, 2018 vs 2023 (USD Million)
4.5 Market, By End User, 2018 vs 2023 (USD Million)
4.6 Geographical Snapshot of the Global Market

 

5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Declining Fertility Rate
5.2.1.2 Rising Number of Fertility Clinics Worldwide
5.2.1.3 Technological Advancements
5.2.1.3.1 Advancements in Infertility Treatment Devices
5.2.1.3.1 Increase in the Use of Time-Lapse Technology
5.2.1.4 Increasing Public-Private Investments, Funds, and Grants
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Assisted Reproductive Techniques in Developed Markets
5.2.2.2 Unsupportive Government Regulations
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.1.1 Improving Healthcare Infrastructure
5.2.3.1.2 Increasing Medical Tourism Due to Low Treatment Costs
5.2.3.2 Use of Fertility Treatment Options By Single Parents and Same-Sex Couples
5.2.4 Challenges
5.2.4.1 Concerns Related to Art Procedures
5.2.4.2 Reduced Efficacy Among Older Women

 

6 Infertility Treatment Market, By Product (Page No. – 51)
6.1 Introduction
6.2 Equipment
6.2.1 Microscopes
6.2.1.1 Growing Technological Advancements in the Field of Microscopy Resulting in the Growing Adoption of Microscopes
6.2.2 Imaging Systems
6.2.2.1 Emergence of Time-Lapse Imaging Systems Driving the Growth of the Infertility Treatment Imaging Systems Market
6.2.3 Sperm Analyzer Systems
6.2.3.1 Automated Sperm Analyzer Systems Permitting Internal and External Quality Control and Better Reproducibility
6.2.4 Ovum Aspiration Pumps
6.2.4.1 Ovum Aspiration Pumps Enable Smooth Collection of Oocytes During Infertility Treatment Procedures
6.2.5 Micromanipulator Systems
6.2.5.1 Micromanipulators are Commonly Used for the Treatment of Male Infertility, Particularly Cases Pertaining to Poor Sperm Quantity/Mobility
6.2.6 Incubators
6.2.6.1 Incubators Play A Vital Role in Embryo Development and Improved Clinical Outcomes
6.2.7 Gas Analyzers
6.2.7.1 Gas Analyzers Contain Multiple Ports Enabling Analysis of Sequential Gas Samples
6.2.8 Laser Systems
6.2.8.1 The Common Applications of Laser Systems Include Treament of Stress Urinary Incontinence and Vaginal Tightening
6.2.9 Cryosystems
6.2.9.1 Demand for Cryosystems is on the Rise as Women are Seeking to Extend Their Childbearing Years
6.3 Media & Consumables
6.3.1 Easy Availability of Culture Media Coupled With the Growing Awareness Among Individuals Driving the Growth of the Media & Consumables Segment
6.4 Accessories
6.4.1 Anti-Vibration Tables are Commonly Used for IVF Treatments to Provide A Smooth Workspace During Procedures

 

7 Infertility Treatment Market, By Procedure (Page No. – 65)
7.1 Introduction
7.2 Assisted Reproductive Technology
7.2.1 in Vitro Fertilization
7.2.1.1 Intracytoplasmic Morphologically Selected Sperm Injection
7.2.1.1.1 Imsi is Highly Recommended in Patients With A Low Sperm Count and Recurrent Implantation Failure
7.2.1.2 Gamete Donation
7.2.1.2.1 Increase in the Number of Women Registering as Egg Donors is A Key Factor Aiding Market Growth
7.2.2 Intracytoplasmic Sperm Injection
7.2.2.1 Icsi is A Specialized Form of IVF Involving Fertilization Used Commonly in Male Infertility Treatment Procedures
7.2.3 Surrogacy
7.2.3.1 High Success Rates Guaranteed and Achieved With the Help of Surrogacy are Driving Market Growth
7.3 Artificial Insemination
7.3.1 Intrauterine Insemination
7.3.1.1 Limited Risk of Complications During Pregnancy and High Success Rates Driving Market Demand for Iui Procedures
7.3.2 Intracervical Insemination
7.3.2.1 Low Cost of Procedure as Compared to Other AI Procedures Leading to Increased Adoption
7.3.3 Intratubal Insemination
7.3.3.1 Better Chances of Successful Pregnancies Using Iti to Drive the Demand for This Procedure
7.4 Fertility Surgery
7.4.1 Laparoscopy
7.4.1.1 Laparoscopy Allows for the Biopsy of Suspect Growths and Cysts That Hamper Fertility
7.4.2 Hysteroscopy
7.4.2.1 Growing Demand for Minimally Invasive Procedures Driving the Adoption of Hysteroscopy Infertility Treatment Surgeries Globally
7.4.3 Myomectomy
7.4.3.1 Advantages of Myomectomy in Alleviating Problems Caused Due to Fibroids While Preserving Future Fertility to Drive the Demand for This Surgery
7.4.4 Laparotomy
7.4.4.1 Laparotomy is Used in Common Infertility Surgeries That Require Large Exposure to the Reproductive System
7.4.5 Tubal Ligation Reversal
7.4.5.1 Tubal Ligation Reversal is Performed Only in Women Who Still Have A Large Portion of Healthy Fallopian Tube Remaining
7.4.6 Varicocelectomy
7.4.6.1 Adoption of Varicocelectomy is High Among Patients and Results in A High Chance of Improved Fertility With Reduced Complications
7.4.7 Microsurgical Reconstruction
7.4.7.1 Vasovasostomy
7.4.7.1.1 Vasovasostomy is A Reversal Surgery Commonly Used in the Treatment of Infertility in Men
7.4.7.2 Vasoepididymostomy
7.4.7.2.1 Vasoepididymostomy Provides A Higher Pregnancy Rate Than IVF With Icsi
7.5 Other Infertility Treatment Procedures

 

8 Infertility Treatment Market, By Patient Type (Page No. – 80)
8.1 Introduction
8.2 Female Infertility Treatment
8.2.1 Increasing Female Infertility Rates to Drive the Growth of the Female Infertility Treatment Market
8.3 Male Infertility Treatment
8.3.1 Growing Adoption of Male Infertility Treatment Procedures to Provide Potential Growth Opportunities

 

9 Infertility Treatment Market, By End User (Page No. – 84)
9.1 Introduction
9.2 Fertility Centers
9.2.1 Growing Number of Infertility Treatment Centers Worldwide Driving Growth of This Segment
9.3 Hospitals and Surgical Clinics
9.3.1 Initiatives Undertaken By Governments to Increase the Number of Hospitals Equipped to Perform Infertility Treatment Procedures Contributing to Market Growth
9.4 Research Institutes
9.4.1 Growing Need for Improving the Clinical Efficacy of Various Infertility Treatment Options Driving Market Growth in Research Institutes
9.5 Cryobanks
9.5.1 Increasing Number of Art Procedures Using Donor Sperm and Donor Eggs for Infertility Treatment Driving the Demand for Cryobanks

 

10 Infertility Treatment Market, By Region (Page No. – 91)
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 US to Dominate the Infertility Treatment Market in North America
10.2.2 Canada
10.2.2.1 Government Initiatives and Legislations for Same-Sex Marriages to Drive Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Favorable Funding Scenario for IVF Treatments in Germany to Drive the Growth of the Infertility Treatment Market in the Country
10.3.2 Uk
10.3.2.1 Increase in the Number of IVF Cycles in the UK Contributing to Market Growth
10.3.3 France
10.3.3.1 The Art Segment Dominated the Infertility Treatment Procedures Market in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Growing Awareness has Served to Boost the Adoption of IVF Procedures in Japan
10.4.2 China
10.4.2.1 Declining Newborn Population and Birth Rate in China to Drive the Demand for Infertility Treatment Procedures in the Country
10.4.3 India
10.4.3.1 Rising Fertility Medical Tourism Offering High-Growth Opportunities for the Infertility Treatment Market in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.1.1 Latin America to Account for the Largest Share of the Rest of the World Infertility Treatment Market
10.5.2 Middle East & Africa
10.5.2.1 Rising Incidence of Male-Factor Infertility to Drive Market Growth During the Forecast Period

 

11 Competitive Landscape (Page No. – 131)
11.1 Overview
11.2 Infertility Treatment: Market Share Analysis, 2017
11.3 Competitive Scenario

 

12 Company Profiles (Page No. – 135)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Cook Group Incorporated
12.2 Esco Micro Pte. Ltd.
12.3 Genea Limited
12.4 Hamilton Throne, Ltd.
12.5 Ihmedical A/S
12.6 Irvine Scientific (A Member of Jx Holdings Group)
12.7 IVFTech Aps
12.8 Kitazato Corporation
12.9 Medgyn Products, Inc.
12.10 Rocket Medical PLC
12.11 Somatex Medical Technologies GmbH
12.12 The Baker Company, Inc.
12.13 The Cooper Companies, Inc.
12.14 Thermo Fisher Scientific
12.15 Vitrolife Ab
12.16 Zeiss Group

 

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

 

13 Appendix (Page No. – 168)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

 
List of Tables (106 Tables)

 

Table 1 Infertility Treatment Market, By Product, 2016–2023 (USD Million)
Table 2 Infertility Treatment Equipment Market, By Type, 2016–2023 (USD Million)
Table 3 Infertility Treatment Equipment Market, By Region, 2016–2023 (USD Million)
Table 4 Microscopes Market, By Region, 2016–2023 (USD Million)
Table 5 Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 6 Sperm Analyzer Systems Market, By Region, 2016–2023 (USD Million)
Table 7 Ovum Aspiration Pumps Market, By Region, 2016–2023 (USD Million)
Table 8 Micromanipulator Systems Market, By Region, 2016–2023 (USD Million)
Table 9 Incubators Market, By Region, 2016–2023 (USD Million)
Table 10 Gas Analyzers Market, By Region, 2016–2023 (USD Million)
Table 11 Laser Systems Market, By Region, 2016–2023 (USD Million)
Table 12 Cryosystems Market, By Region, 2016–2023 (USD Million)
Table 13 Media & Consumables Market, By Region, 2016–2023 (USD Million)
Table 14 Accessories Market, By Region, 2016–2023 (USD Million)
Table 15 Infertility Treatment Market, By Procedure, 2016-2023 (USD Million)
Table 16 Assisted Reproductive Technology Market, By Type, 2016–2023 (USD Million)
Table 17 Assisted Reproductive Technology Market, By Region, 2016–2023 (USD Million)
Table 18 in Vitro Fertilization Market, By Region, 2016–2023 (USD Million)
Table 19 Intracytoplasmic Sperm Injection Market, By Region, 2016–2023 (USD Million)
Table 20 Surrogacy Market, By Region, 2016–2023 (USD Million)
Table 21 Artificial Insemination Market, By Type, 2016–2023 (USD Million)
Table 22 Artificial Insemination Market, By Region, 2016–2023 (USD Million)
Table 23 Fertility Surgery Market, By Type, 2016–2023 (USD Million)
Table 24 Fertility Surgery Market, By Region, 2016–2023 (USD Million)
Table 25 Other Infertility Treatment Procedures Market, By Region, 2016–2023 (USD Million)
Table 26 Infertility Treatment Market, By Patient Type, 2016–2023 (USD Million)
Table 27 Female Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 28 Male Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Fertility Clinics, By Region, 2016–2023 (USD Million)
Table 31 Infertility Treatment Devices Market for Hospitals and Surgical Clinics, By Region, 2016–2023 (USD Million)
Table 32 Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 33 Market for Cryobanks, By Region, 2016–2023 (USD Million)
Table 34 Market, By Region, 2016–2023 (USD Million)
Table 35 North America: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 36 North America: Market, By Procedure, 2016–2023 (USD Million)
Table 37 North America: Market, By Product, 2016–2023 (USD Million)
Table 38 North America: Market, By Patient Type, 2016–2023 (USD Million)
Table 39 North America: Market, By End User, 2016–2023 (USD Million)
Table 40 US: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 41 US: Market, By Product, 2016–2023 (USD Million)
Table 42 US: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Patient Type, 2016–2023 (USD Million)
Table 44 Canada: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 45 Canada: Market, By Product, 2016–2023 (USD Million)
Table 46 Canada: Market, By End User, 2016–2023 (USD Million)
Table 47 Canada: Market, By Patient Type, 2016–2023 (USD Million)
Table 48 Europe: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Market, By Procedure, 2016–2023 (USD Million)
Table 50 Europe: Market, By Product, 2016–2023 (USD Million)
Table 51 Europe: Market, By Patient Type, 2016–2023 (USD Million)
Table 52 Europe: Market, By End User, 2016–2023 (USD Million)
Table 53 Germany: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 54 Germany: Market, By Product, 2016–2023 (USD Million)
Table 55 Germany: Market, By Patient Type, 2016–2023 (USD Million)
Table 56 Germany: Market, By End User, 2016–2023 (USD Million)
Table 57 UK: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 58 UK: Market, By Product, 2016–2023 (USD Million)
Table 59 UK: Market, By Patient Type, 2016–2023 (USD Million)
Table 60 UK: Market, By End User, 2016–2023 (USD Million)
Table 61 France: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 62 France: Market, By Product, 2016–2023 (USD Million)
Table 63 France: Market, By Patient Type, 2016–2023 (USD Million)
Table 64 France: Market, By End User, 2016–2023 (USD Million)
Table 65 RoE: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 66 RoE: Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Market, By End User, 2016–2023 (USD Million)
Table 68 RoE: Market, By Patient Type, 2016–2023 (USD Million)
Table 69 APAC: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 70 APAC: Market, By Procedure, 2016–2023 (USD Million)
Table 71 APAC: Market, By Product, 2016–2023 (USD Million)
Table 72 APAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 73 APAC: Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 75 Japan: Market, By Product, 2016–2023 (USD Million)
Table 76 Japan: Market, By Patient Type, 2016–2023 (USD Million)
Table 77 Japan: Market, By End User, 2016–2023 (USD Million)
Table 78 China: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 79 China: Market, By Product, 2016–2023 (USD Million)
Table 80 China: Market, By Patient Type, 2016–2023 (USD Million)
Table 81 China: Market, By End User, 2016–2023 (USD Million)
Table 82 India: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 83 India: Market, By Product, 2016–2023 (USD Million)
Table 84 India: Market, By Patient Type, 2016–2023 (USD Million)
Table 85 India: Market, By End User, 2016–2023 (USD Million)
Table 86 RoAPAC: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 87 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 88 RoAPAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 89 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 90 RoW: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 91 RoW: Market, By Procedure, 2016–2023 (USD Million)
Table 92 RoW: Market, By Product, 2016–2023 (USD Million)
Table 93 RoW: Market, By Patient Type, 2016–2023 (USD Million)
Table 94 RoW: Market, By End User, 2016–2023 (USD Million)
Table 95 Latin America: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 96 Latin America: Market, By Product, 2016–2023 (USD Million)
Table 97 Latin America: Market, By Patient Type, 2016–2023 (USD Million)
Table 98 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 99 Middle East & Africa: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 100 Middle East & Africa: Market, By Product, 2016–2023 (USD Million)
Table 101 Middle East & Africa: Market, By Patient Type, 2016–2023 (USD Million)
Table 102 Middle East & Africa: Market, By End User, 2016–2023 (USD Million)
Table 103 Product Launches and Enhancements
Table 104 Expansions
Table 105 Collaborations, Partnerships, and Agreements
Table 106 Acquisitions

 
List of Figures (32 Figures)

 

Figure 1 Infertility Treatment Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Infertility Treatment Market
Figure 4 Top-Down Approach Market Size Estimation: Infertility Treatment Market
Figure 5 Data Triangulation Methodology
Figure 6 Infertility Treatment Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 7 Market Share, By Product, 2018
Figure 8 Market Share, By Patient Type, 2018
Figure 9 Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Geographic Snapshot of the Infertility Treatment Market
Figure 11 Declining Global Fertility Rate—Major Factor Driving Market Growth
Figure 12 Media & Consumables Market in the Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 13 Assisted Reproductive Technology Segment to Dominate the Asia Pacific Infertility Treatment Market in 2018
Figure 14 Female Infertility Treatment Segment Will Continue to Dominate the Global Market in 2023
Figure 15 Fertility Centers to Dominate the Infertility Treatment Market During the Forecast Period
Figure 16 Asia Pacific to Register the Highest Growth in the Forecast Period
Figure 17 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Declining Global Fertility Rate (1960–2016)
Figure 19 Global Market, By Product, 2018 vs 2023 (USD Million)
Figure 20 Global Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 21 Female Infertility Treatment Segment to Dominate the Market During the Forecast Period
Figure 22 Global Market, By End User, 2018 vs 2023 (USD Million)
Figure 23 Global Market, By Region, 2018 vs 2023 (USD Million)
Figure 24 North America: Infertility Treatment Market Snapshot
Figure 25 Europe: Infertility Treatment Market Snapshot
Figure 26 Asia Pacific: Infertility Treatment Market Snapshot
Figure 27 The Cooper Companies Held the Leading Position in the Infertility Treatment Market, 2017
Figure 28 Hamilton Throne Ltd.: Company Snapshot
Figure 29 The Cooper Companies: Company Snapshot
Figure 30 Thermo Fisher Scientific: Company Snapshot
Figure 31 Vitrolife: Company Snapshot
Figure 32 Zeiss Group: Company Snapshot

 



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[不妊治療の世界市場予測(~2023年)]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆